MYC and neuroblastoma: Surprisingly, MYC regulation and cellular response to BET inhibition differ between hematologic and solid tumor models such as neuroblastoma, as MYC suppression was variable in MYC-expressing neuroblastoma cell lines and did not positively correlate with sensitivity to I-BET726.